Verdiperstat is a first‐in‐class, potent, selective, brain‐permeable MPO inhibitor produced by Biohaven Pharmaceuticals Inc. Treatment with verdiperstat has been shown to decrease microglia activation in multiple system atrophy (MSA) [46] and PD [43]. Here, MPO is linked to multiple system atrophy.